.slides > li:first-child { display: block; } .image__fallback { width: 100vw; display: block !important; max-width: 100vw !important; margin-bottom: 0; } .image__fallback + .hsContainer__image { display: none !important; } .hsContainer { height: auto !important; } .no-js-only { display: inherit !important; } .icon-cart.cart-button { display: none; } .lazyload, .cart_page_image img { opacity: 1; -webkit-filter: blur(0); filter: blur(0); } .bcg .hsContent { background-color: transparent; } .animate_right, .animate_left, .animate_up, .animate_down { opacity: 1; } .flexslider .slides>li { display: block; } .product_section .product_form { opacity: 1; } .multi_select, form .select { display: block !important; } .swatch_options { display: none; }

Australian manufacturer thrives at intersection of technology and human wellbeing

January 11, 2016

From Manufacturers' Monthly:

Ringwood’s Trajan Scientific and Medical operates in two acknowledged areas of competitive advantage for Australia: advanced manufacturing and medical technology. Brent Balinski spoke to company CEO Stephen Tomisich about how it plans to change the world of healthcare.

Read the full article at Manufacturers' Monthly: Australian manufacturer thrives at intersection of technology and human wellbeing

Stephen Tomisich, Director and Chief Executive Officer, Trajan Scientific and Medical

Also in News

Trajan collaborates with Monash University for the development of HDX training centre

February 03, 2023

Baker Institute research leads to simple tests for heart and diabetes disease

January 13, 2023

Trajan Scientific and Medical to license the Baker Institute’s lipidomic analysis methodology and metabolic risk scores algorithms.

October 10, 2022

Trajan Scientific and Medical, and the Baker Heart and Diabetes Institute, have reached an in-principle understanding for Trajan to license the Baker Institute’s lipidomic analysis methodology and metabolic risk scores algorithms.